Clinical Trials Browser

Not yet recruiting × Immunoglobulin Light-chain Amyloidosis × 1 year × Clear all

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT07335887 2026-01-13

Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

Phase 2 Not yet recruiting

39 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06971848 2025-07-11

ETCABIO

Phase NA Not yet recruiting

70 enrolled

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07055724 2025-07-09

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

Phase 2 Not yet recruiting

17 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis

Clinical Trials

ALANIS

Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

ETCABIO

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis